Plantar Fasciitis Randomized Clinical Control Trial
ConditionPlantar Fascitis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Pennsylvania
About this trial
The primary aim of this clinical experiment is to compare, in terms of pain relief measured using the 10-cm visual analog scale (VAS) pain score (5-7), the clinical results of ultrasound-guided injection (USGI) versus anatomic topography-guided injection (ATGI) of corticosteroid for the treatment of proximal PF. Secondary aims will be to compare foot-related quality of life, as measured using the Foot Function Index (FFI)and the Bristol Foot Score (BFS), between the injection groups, and also to compare the pre-injection to late-term post-injection thickness of the plantar fascia as measured in the nested USGI group.
Eligibility criteria
Qualifiers
Pain on palpation along the proximal plantar fascia with or without radiographic evidence of a plantar calcaneal bone spur
≥18 years of age
Male or non-pregnant female of any ethnicity or race
Active, former or non smoker
Disqualifiers
Known drug or alcohol dependence
Chronic pain syndrome or lumbosacral radiculitis
Neurological condition that requires the use of analgesic medications or anti-seizure or neuroleptic medications
Peripheral vascular disease that results in rest pain or intermittent claudication or venous stasis ulceration
Trial design
Treatments tested in this trial
- Local Steroid Injection into the plantar heel
- Ultrasound Guided Injection
- Anatomical Guided injection
Treatment groups
62 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov